| 13623 |
Leronlimab (Pro 140) Cliff Notes What is it?  (37) |
trding |
12/24/2019 8:09:27 PM |
| 112006 |
Leronlimab - Disease List (currently 90) (updated (28) |
ohm20 |
12/09/2021 8:15:12 AM |
| 144440 |
Leronlimab Regulator List (a work in progress) = (14) |
ohm20 |
06/12/2024 7:33:56 PM |
| 145805 |
Here's some basics on the science - Leronlimab (43) |
ohm20 |
08/21/2024 12:48:53 PM |
|
62139 |
lorbas, why do we need a 2-tailled distribution? |
jk1550 |
10/20/2020 8:15:06 AM |
|
62138 |
B Patterson PR. excerpt Maraviroc, an oral (1) |
dfwl28 |
10/20/2020 8:11:30 AM |
|
62137 |
I thought I read something from the FDA's website |
Eyedr |
10/20/2020 8:11:30 AM |
|
62136 |
https://www.prnewswire.com/news-releases/incelldx |
lorbas |
10/20/2020 8:07:37 AM |
|
62135 |
That Cytodyn is "seeking ongoing guidance from (3) |
ohm20 |
10/20/2020 8:02:21 AM |
|
62134 |
I agree. At face value its hard to read the (1) |
SAF |
10/20/2020 7:59:08 AM |
|
62133 |
Blafarm, Please tell me what is really achieved |
jk1550 |
10/20/2020 7:56:31 AM |
|
62132 |
Figured, good point. |
Riztheinvestor |
10/20/2020 7:56:13 AM |
|
62131 |
"If the DSMB reports that the clinical trial |
Riztheinvestor |
10/20/2020 7:55:05 AM |
|
62130 |
SAF, I believe you are 100% correct, that DSMC (6) |
CTMedic |
10/20/2020 7:50:46 AM |
|
62129 |
That EUA is based on risk/benefit analysis and (5) |
ohm20 |
10/20/2020 7:47:44 AM |
|
62128 |
Odds will be high that none in the LLMab arm need (2) |
blafarm |
10/20/2020 7:47:37 AM |
|
62127 |
Re: 42 day survival, with so many critical (1) |
JLang |
10/20/2020 7:43:13 AM |
|
62126 |
That's $3.24 USD +/- (2.74 euros) in case you |
Eyedr |
10/20/2020 7:42:33 AM |
|
62125 |
Pushes any positive news out to @ January 20th. (2) |
Boatbuilder |
10/20/2020 7:42:25 AM |
|
62124 |
Ohm, do you think unblinding now would be a good |
generactor |
10/20/2020 7:41:43 AM |
|
62123 |
So, they ARE changing the endpoint? It is |
invisioner |
10/20/2020 7:41:27 AM |
|
62120 |
DSMC also requests another data review when (3) |
ohm20 |
10/20/2020 7:39:22 AM |
|
62119 |
https://www.bloomberg.com/quote/296:GR Up 15% on |
Eyedr |
10/20/2020 7:39:17 AM |
|
62118 |
Odds are that stat sig was met, but they're just  (1) |
JLang |
10/20/2020 7:37:15 AM |
|
62117 |
Playing with some numbers for 75% enrollment... |
lorbas |
10/20/2020 7:35:51 AM |
|
62116 |
We should have at least 5 additional sites in the (1) |
ohm20 |
10/20/2020 7:33:29 AM |
|
62115 |
Well, best case scenario might be enrollment in 4 (5) |
blafarm |
10/20/2020 7:28:35 AM |
|
62114 |
Wait, why 42? I am thinking 28. Where does the 42 |
invisioner |
10/20/2020 7:28:17 AM |
|
62113 |
Great summary of the issues and history of these (3) |
JLang |
10/20/2020 7:27:05 AM |
|
62112 |
I totally agree with and also feel the (1) |
invisioner |
10/20/2020 7:27:05 AM |
|
62111 |
It's obviously 42 days after the 293rd patient is (8) |
ohm20 |
10/20/2020 7:23:08 AM |
|
62110 |
And furthermore, if the trial was close to a p (5) |
invisioner |
10/20/2020 7:22:18 AM |
|
62109 |
Yes. Otherwise there would be no reason to add |
KenChowder |
10/20/2020 7:22:16 AM |
|
62108 |
I think because NP is not going to take this (4) |
LaundryMoney |
10/20/2020 7:20:08 AM |
|
62107 |
Generactor Wrote:So the added 2 weeks to the (5) |
blafarm |
10/20/2020 7:18:42 AM |
|
62106 |
The extension to 42 days should cover any (7) |
ohm20 |
10/20/2020 7:12:32 AM |
|
62105 |
I do think that but it won't be until the end of (1) |
invisioner |
10/20/2020 7:11:19 AM |
|
62104 |
That is so weird. Why didn't Nader just release (3) |
invisioner |
10/20/2020 7:08:19 AM |
|
62103 |
We have also seen the positive statistical effect (3) |
blafarm |
10/20/2020 7:06:17 AM |
|
62102 |
ohm How does decreased overall death rate come (1) |
Daltondog |
10/20/2020 7:03:47 AM |
|
62101 |
Now that we know the trial is continuing on, I'm (5) |
Respert24 |
10/20/2020 7:03:07 AM |
|
62100 |
Excellent article on zerohedge (4) |
Doctor_Frank_Rocco |
10/20/2020 7:02:16 AM |
|
62099 |
If halt is .005 - using a double binomial test, (4) |
ohm20 |
10/20/2020 6:59:54 AM |
|
62098 |
Do you think this implies that the DSMC expects |
SAF |
10/20/2020 6:55:00 AM |
|
62097 |
Aside from repeating my observation that CytoDyn |
blafarm |
10/20/2020 6:48:38 AM |
|
62095 |
So the added 2 weeks to the monitoring period (2) |
generactor |
10/20/2020 6:46:44 AM |
|
62094 |
http://themanilapost.net/chiral-pharma-cytodyn-in (1) |
docj |
10/20/2020 6:37:47 AM |
|
62093 |
EUA is out of the question (1) |
generactor |
10/20/2020 6:36:40 AM |
|
62092 |
For what it's worth, it's up 13% in |
KenChowder |
10/20/2020 6:34:16 AM |
|
62091 |
Good news ! Does this mean EAUs out of the |
Riztheinvestor |
10/20/2020 6:30:18 AM |
|
62089 |
They must have missed statistical significance by (2) |
KenChowder |
10/20/2020 6:22:42 AM |
|
62087 |
Encouraging news. Important points: - No (11) |
lorbas |
10/20/2020 6:12:54 AM |
|
62086 |
CytoDyn Receives Positive DSMC Recommendation (4) |
lorbas |
10/20/2020 6:09:09 AM |
|
62085 |
https://www.cytodyn.com/newsroom/press-releases/d (1) |
docj |
10/20/2020 6:03:59 AM |
